WallStreetZenWallStreetZen

NASDAQ: OTLK
Outlook Therapeutics Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

OTLK past revenue growth

How has OTLK's revenue growth performed historically?
Company
N/A
Industry
149.3%
Market
17.29%
OTLK's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
OTLK's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance

OTLK earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$51.5M
Current Profit Margin
0%

OTLK Return on Equity

Current Company
N/A
Current Industry
-63.5%
Current Market
188%

Be the first to know when OTLK announces earnings.

OTLK Return on Assets

Current Company
-135.1%
Current Industry
2.9%
OTLK is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

OTLK Return on Capital Employed

Current Company
216.49%
Current Industry
19.5%
OTLK has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

OTLK vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
OTLK$0.00-$52.51M-$51.50M-100.00%N/A
CLSD$8.23M-$32.42M-$32.49M+207.34%N/A
BCAB$0.00-$122.24M-$123.46M-100.00%N/A
VIGL$0.00-$80.88M-$82.64MN/AN/A
BLUE$21.73M-$95.08M-$91.17M-11.27%N/A
View Top Biotech Stocks

OTLK earnings dates

Next earnings date
May 13, 2024

Outlook Therapeutics Earnings & Revenue FAQ

What were OTLK's earnings last quarter?

On Invalid Date, Outlook Therapeutics (NASDAQ: OTLK) reported Q4 2023 earnings per share (EPS) of -$0.80, up 50% year over year. Total Outlook Therapeutics earnings for the quarter were -$11.18 million. In the same quarter last year, Outlook Therapeutics's earnings per share (EPS) was -$1.60.

If you're new to stock investing, here's how to buy Outlook Therapeutics stock.

What was OTLK's earnings growth in the past year?

As of Q2 2024, Outlook Therapeutics's earnings has grown year over year. Outlook Therapeutics's earnings in the past year totalled -$51.50 million.

What is OTLK's earnings date?

Outlook Therapeutics's earnings date is Invalid Date. Add OTLK to your watchlist to be reminded of OTLK's next earnings announcement.

What was OTLK's revenue last quarter?

On Invalid Date, Outlook Therapeutics (NASDAQ: OTLK) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Outlook Therapeutics's revenue was $0.00.

What was OTLK's revenue growth in the past year?

As of Q2 2024, Outlook Therapeutics's revenue has grown null year over year. Outlook Therapeutics's revenue in the past year totalled $0.00.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.